GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.37
+0.75 (2.05%)
At close: May 12, 2025, 4:00 PM
36.74
-0.63 (-1.69%)
Pre-market: May 13, 2025, 9:13 AM EDT
GSK Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for GSK stock has a target of 47, which predicts a 25.77% increase from the current stock price of 37.37.
Price Target: $47.00 (+25.77%)
Analyst Consensus: Hold
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for GSK stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +41.82% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +25.77% | May 30, 2024 |
Financial Forecast
Revenue This Year
33.63B
from 31.38B
Increased by 7.19%
Revenue Next Year
35.43B
from 33.63B
Increased by 5.34%
EPS This Year
1.73
from 0.62
Increased by 178.25%
EPS Next Year
1.92
from 1.73
Increased by 10.93%
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.1B | 38.4B | 41.6B | ||
| Avg | 33.6B | 35.4B | 36.9B | ||
| Low | 31.3B | 32.6B | 33.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.9% | 14.3% | 17.3% | ||
| Avg | 7.2% | 5.3% | 4.0% | ||
| Low | -0.2% | -3.1% | -6.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.89 | 2.18 | 2.50 | ||
| Avg | 1.73 | 1.92 | 2.05 | ||
| Low | 1.46 | 1.61 | 1.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 203.4% | 26.0% | 30.2% | ||
| Avg | 178.2% | 10.9% | 6.6% | ||
| Low | 134.6% | -7.0% | -13.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.